ALS Better Care Act
Sponsor

Full profile: /officials/S001145
Source: Congress.gov · FEC
Cosponsors (14)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2026-02-03
Source: Congress.gov
Committee Activity
Currently in
- House Committee on Ways and MeansReferred To · 2026-02-03
- House Committee on Energy and CommerceReferred To · 2026-02-03
Previously
- Ways and Means CommitteeReferred To · 2026-02-03
- Energy and Commerce CommitteeReferred To · 2026-02-03
Plain-English Summary
The bill would improve healthcare coverage and treatment options for people with ALS (amyotrophic lateral sclerosis), a serious neurological disease that gradually weakens muscles. It likely addresses insurance coverage for ALS medications and therapies, potentially expands access to specialized care, and may adjust how Medicare and Medicaid reimburse providers treating ALS patients. The changes would affect both ALS patients seeking treatment and healthcare providers who care for them.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HR10792FTC Whistleblower Act of 2026Referred to Committee · 2026-10-09
- HR10701FTC Autonomy ActReferred to Committee · 2026-10-01
- HR10600Abortion is Health Care Everywhere Act of 2026Referred to Committee · 2026-09-24
- HR10459Patriotic Corporations of America Act of 2026Referred to Committee · 2026-09-16